Cytokeratin characterization of human prostatic carcinoma and its derived cell lines.
Two murine monoclonal anti-cytokeratin antibodies with defined specificity were shown to distinguish between basal cells and luminal cells in human prostate tissue. Forty-one biopsies or transurethral resection specimens were characterized using these two antibodies. In cases of benign prostatic hyperplasia, focal loss of the basal cell layer was noted in areas of glandular proliferation. Ten cases of adenocarcinoma of the prostate, varying in Gleason's histological grade from 2 to 4, were also studied. In each case the carcinoma was shown to represent the luminal cell phenotype with no evidence of involvement of the basal cell phenotype. An analysis of three established metastatic prostatic carcinoma cell lines (DU-145, PC-3, and LNCaP) using two-dimensional electrophoresis showed that the cytokeratin complement of each cell line was slightly different but retained the phenotype of the luminal cell. It was concluded that during both hyperplasia and neoplastic transformation of the prostate, the luminal cell phenotype is primarily involved and that the basal cell phenotype does not appear to contribute to either intraluminal proliferation or invasive cell populations.
D000911:Antibodies, Monoclonal / Q000276:immunology; D001943:Breast Neoplasms / Q000032:analysis; D002277:Carcinoma / Q000032:analysis*; D002460:Cell Line; D006801:Humans; D007633:Keratins / Q000032:analysis* / Q000276:immunology; D008297:Male; D010641:Phenotype; D011467:Prostate / Q000032:analysis; D011471:Prostatic Neoplasms / Q000032:analysis*
D000911:Antibodies, Monoclonal; D007633:Keratins